Ergomed (ERGO.L, ERGO LN)
- 683.5
- 50.8
- 81.3
Company Profile
Ergomed is a UK-listed healthcare services business operating across two divisions: Pharmacovigilance, which provides services relating to drug safety, and Clinical Research Services, which provides services relating to organising, executing and managing the clinical trial of drugs. The business is predominantly based in North America, and both divisions have high organic growth rates with a blended average above 10% per annum. High customer retention and order books provides strong visibility on growth and earnings streams.
Major Shareholders | % |
Reljanovic Miroslav | 17.9 |
Octopus Investments Ltd. | 11.7 |
Abrdn Investment Management | 7.5 |
BlackRock Invest. Mgt (UK) Ltd. | 4.1 |
Sand Grove Capital Management LLP | 4.0 |